Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0437
+0.0008 (1.86%)
Mar 26, 2026, 11:53 AM EST
Bioxytran Employees
Bioxytran had 3 employees as of December 31, 2023. The number of employees increased by 1 or 50.00% compared to the previous year.
Employees
3
Change (1Y)
1
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
5.80M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | 2 | 0 | - |
| Dec 31, 2019 | 2 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 146 |
| NKGen Biotech | 26 |
| Brainstorm Cell Therapeutics | 23 |
| Mosaic ImmunoEngineering | 8 |
| AccuStem Sciences | 2 |
| Synlogic | 1 |
Bioxytran News
- 6 days ago - BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT - GlobeNewsWire
- 22 days ago - Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M - GlobeNewsWire
- 24 days ago - Bioxytran, Inc. Reports Positive Phase 1b/2a Clinical Study Results for ProLectin-M, a Broad-Range Antiviral Drug in Mild to Moderate COVID-19 - Accesswire
- 6 weeks ago - Bioxytran Reports Positive Phase 2 Results Demonstrating Rapid Viral Clearance with ProLectin-MBioxytran - GlobeNewsWire
- 7 weeks ago - Bioxytran and University of Minnesota Launch Sponsored Research Collaboration to Advance Novel Carbohydrate-Based Therapeutics - GlobeNewsWire
- 4 months ago - Bioxytran Announces Initiation of Coverage of its Stock by Independent Research - GlobeNewsWire
- 5 months ago - Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug - GlobeNewsWire
- 7 months ago - Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation - GlobeNewsWire